Table: Torii Pharmaceutical - Q1 parent results
Apr 28 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2022 Mar 31, 2021 Dec 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 10.96 9.90 48.20
(+3.4 pct)
Operating 1.29 689 mln 5.20
(+87.3 pct) (-44.9 pct) (+11.7 pct)
Recurring 1.25 650 mln 5.40
(+91.6 pct) (-50.6 pct) (+11.4 pct)
Net 882 mln 436 mln 3.80
(+102.3 pct) (-49.5 pct) (+12.6 pct)
EPS 31.40 yen 15.53 yen 135.27 yen
EPS Diluted 15.53 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)